| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |